Author:
Verhoest G.,Dolley-Hitze T.,Jouan F.,Bensalah K.,Arlot-Bonnemains Y.,Dugay F.,Belaud-Rotureau M.-A.,Rioux-Leclercq N.,Vigneau C.
Reference59 articles.
1. Récepteurs de type 1 à l’angiotensine-2 (AT1R) et cancers;Dolley-Hitze;Nephrol Ther,2013
2. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials;Sipahi;Lancet Oncol,2010
3. Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk;Sipahi;Am J Cardiol,2011
4. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769, individuals;ARB Trialists Collaboration;J Hypertens,2011
5. Angiotensin-receptor blockade, cancer, and concerns;Meredith;Lancet Oncol,2010
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献